Inventor · disambiguated record
Shimiao Wang
Also filed as: WANG SHIMIAO
31 granted patents·7 pending applications·123 citations·filing 2003–2023
96Inventor score
Top patents by PatentIndex Score
38 records- 0197US10981894B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2020·Granted Apr 20, 2021·6 cites·20 claims
- 0295US10604507B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Mar 31, 2020·7 cites·20 claims
- 0395US10562884B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Feb 18, 2020·7 cites·20 claims
- 0494US11566015B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2021·Granted Jan 31, 2023·2 cites·36 claims
- 0594US11479540B2Nonpeptide somatostatin type 5 receptor agonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2020·Granted Oct 25, 2022·5 cites·43 claims
- 0693US10875839B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Dec 29, 2020·5 cites·10 claims
- 0793US9896432B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2017·Granted Feb 20, 2018·11 cites·20 claims
- 0892US10597377B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Mar 24, 2020·8 cites·9 claims
- 0992US10351547B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2017·Granted Jul 16, 2019·9 cites·24 claims
- 1092US9902703B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2016·Granted Feb 27, 2018·8 cites·17 claims
- 1191US11414397B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2020·Granted Aug 16, 2022·2 cites·23 claims
- 1288US12479828B2Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2023·Granted Nov 25, 2025·0 cites·22 claims
- 1388US9233968B1Kinase inhibitorsALLERGAN INC·Filed 2014·Granted Jan 12, 2016·5 cites·6 claims
- 1488US7060844B2(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsALLERGAN INC·Filed 2003·Granted Jun 13, 2006·29 cites·3 claims
- 1587US9371314B2Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Jun 21, 2016·3 cites·18 claims
- 1685US2024109866A1Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1780US11608335B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2019·Granted Mar 21, 2023·2 cites·21 claims
- 1880US7915443B2Sulfoximines as kinase inhibitorsALLERGAN INC·Filed 2007·Granted Mar 29, 2011·5 cites·44 claims
- 1980US2022380337A1Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2079US7977351B2Heteroaryl dihydroindolones as kinase inhibitorsALLERGAN INC·Filed 2007·Granted Jul 12, 2011·3 cites·19 claims
- 2177US9359336B2Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Jun 7, 2016·1 cites·8 claims
- 2274US8455535B2Heteroaryl dihydroindolones as kinase inhibitorsBORAL SOUGATO·Filed 2011·Granted Jun 4, 2013·3 cites·21 claims
- 2373US2021115029A1Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2020·Application pending·0 cites
- 2469US9266869B2Substituted dialkyl(oxido)-lambda4-sulfanylidene nicotinamide derivatives as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Feb 23, 2016·1 cites·18 claims
- 2568US10633373B2Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Apr 28, 2020·0 cites·2 claims
- 2666US10669265B2Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Jun 2, 2020·0 cites·1 claims
- 2766US2022144802A1Nonpeptide somatostatin type 5 receptor agonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2865US8558002B2Sulfoximines as kinase inhibitorsBORAL SOUGATO·Filed 2011·Granted Oct 15, 2013·1 cites·35 claims
- 2963US9868726B2Pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2016·Granted Jan 16, 2018·0 cites·2 claims
- 3062US10011593B2Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2017·Granted Jul 3, 2018·0 cites·5 claims
- 3160US2023159532A1Parathyroid hormone (pth) receptor antagonists and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3259US9650366B2Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitorsALLERGAN INC·Filed 2016·Granted May 16, 2017·0 cites·2 claims
- 3354US2015166518A1Substituted nicotinamide derivatives as kinase inhibitorsALLERGAN INC·Filed 2014·Application pending·0 cites
- 3451US9403803B2Indole-3-carboxamides as kinase inhibitorsALLERGAN INC·Filed 2014·Granted Aug 2, 2016·0 cites·14 claims
- 3550US9353093B2Indole-1-carboxamides as kinase inhibitorsALLERGAN INC·Filed 2014·Granted May 31, 2016·0 cites·14 claims
- 3647US9567324B2Substituted nicotinamide derivatives as kinase inhibitorsALLERGAN INC·Filed 2016·Granted Feb 14, 2017·0 cites·17 claims
- 3743US11028068B2Somatostatin modulators and uses thereofCRINETICS PHARMACEUTICALS INC·Filed 2018·Granted Jun 8, 2021·0 cites·19 claims
- 3839US2006004084A1(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitorsANDREWS STEVEN W·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shimiao Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →